A Multicenter, Open-Label Study to Evaluate Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-Term Treatment of Bipolar Mania
Phase of Trial: Phase IV
Latest Information Update: 20 Jan 2011
At a glance
- Drugs Risperidone (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Janssen
- 19 Oct 2007 Status changed from in progress to completed.
- 26 Nov 2005 New trial record.